<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609204</url>
  </required_header>
  <id_info>
    <org_study_id>14-426E</org_study_id>
    <nct_id>NCT02609204</nct_id>
  </id_info>
  <brief_title>Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG)</brief_title>
  <acronym>DIOPSYS-ND</acronym>
  <official_title>NOVA™ PERG and FERG: Establishment of Reference Values for PERG and FERG Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wills Eye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wills Eye</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of the study is to compile a normative database for the Neuro Optic Vision
      Assessment (NOVATM) Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG)
      modules. This normalization intends to be included in a probabilistic analysis protocol to
      allow NOVATM PERG/FERG users to identify patients with results outside the normal ranges
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, investigators plan to enroll 50 subjects at Wills Eye Hospital without any eye
      diseases.

      Participants will first undergo a complete eye examination to determine if eligible,
      including visual acuity testing, IOP, and visual field testing.

      If investigators do not find any eye problems during the exam, participants will then be
      tested with the Diopsys NOVA™ PERG &amp; FERG testing systems. For both tests, two electrodes are
      placed on the skin underneath both eyes below the eyelashes. Participants' skin will be
      cleaned before the electrodes are placed on the head. A small amount of gel will be placed on
      the skin where the electrodes will be placed and testing will ensue.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of Pattern Electroretinogram (PERG) module using Diopsys NOVA</measure>
    <time_frame>6 months</time_frame>
    <description>Obtain clinical data from participants with a normal eye examination in order to establish expected normal values of Pattern Electroretinogram(PERG) magnitudes</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Normal Eye Participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>People with normal eye and no history of eye diseases are being recruited for the study and tested on the Diopsys NOVA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diopsys NOVA</intervention_name>
    <description>Every participant will have both eyes tested by the Diopsys NOVA machine using the Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG) modules.</description>
    <arm_group_label>Normal Eye Participants</arm_group_label>
    <other_name>Diopsys-ND</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Normal volunteers age 18 years and older will be recruited and invited to participate in
        the study

        Exclusion Criteria:

          -  A spherical refraction outside + 5.0 D and cylinder correction outside + 3.0 D.

          -  IOP ≥ 22 mm Hg or history of any type of glaucoma in either eye (applanation
             tonometry).

          -  Intraocular surgery in the study eye (except non-complicated cataract or refractive
             surgery performed more than 1 year before enrollment).

          -  Best corrected visual acuity worse than 20/40.

          -  Evidence of diabetic retinopathy, diabetic macular edema, or other vitreo-retinal
             disease in either eye.

          -  Evidence of optic nerve, macula and/or retinal nerve fiber layer abnormality in either
             eye.

          -  Evidence of reproducible (false positives, fixation losses and false negatives ≤ 25%
             with no observable testing artifacts).

          -  Standard Automatic Perimetry (SAP) abnormality in either eye, defined as Pattern
             Standard Deviation significant at p &lt; 5% level, and/or abnormal Glaucoma Hemifield
             test result, and/or any other pattern of loss which is consistent with a neurologic
             and/or ocular disease.

          -  Current or recent (within the past 30 days) use of an agent (by any administering
             method) known to affect visual function.

          -  Inability to obtain a reliable PERG/FERG test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay L Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wills Eye Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wills Eye Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wills Eye</investigator_affiliation>
    <investigator_full_name>L. Jay Katz MD</investigator_full_name>
    <investigator_title>Glaucoma Specialist</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>December 21, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

